Supernus Pharmaceuticals Inc
SWB:S49
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Supernus Pharmaceuticals Inc
SWB:S49
|
US |
|
V
|
Viking Holdings Ltd
NYSE:VIK
|
US |
|
B
|
Ba Airport Leasehold Real Estate Investment Trust
SET:BAREIT
|
TH |
|
S
|
Seafco PCL
SET:SEAFCO
|
TH |
|
R
|
Realty Income Corp
F:RY6
|
US |
|
H
|
Helen of Troy Ltd
XMUN:HT2
|
BM |
|
I
|
Ionis Pharmaceuticals Inc
F:ISI
|
US |
|
Turkcell Iletisim Hizmetleri AS
NYSE:TKC
|
TR |
|
Mizuho Financial Group Inc
F:MZ8A
|
JP |
|
Regions Financial Corp
NYSE:RF
|
US |
|
ArcelorMittal SA
AEX:MT
|
LU |
|
H
|
Hasbro Inc
XBER:HAS
|
US |
|
C
|
Cleveland-Cliffs Inc
XMUN:CVA
|
US |
|
P
|
PTC Inc
XMUN:PMTA
|
US |
|
MFE-MEDIAFOREUROPE NV
MAD:MFEA
|
IT |
|
Invitation Homes Inc
F:4IV
|
US |
|
M
|
Mitsubishi Chemical Holdings Corp
F:M3C
|
JP |
|
Mitrabara Adiperdana Tbk PT
IDX:MBAP
|
ID |
|
P
|
Power Corporation of Canada
F:PCR
|
CA |
|
LG Chem Ltd
KRX:051910
|
KR |
|
Mr DIY Group (M) Bhd
OTC:MDIYF
|
MY |
|
C
|
Compass Group PLC
F:XGR
|
UK |
|
D
|
Ducommun Inc
F:DUM
|
US |
|
SK Hynix Inc
KRX:000660
|
KR |
Dividends
Dividend Yield
Supernus Pharmaceuticals Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Supernus Pharmaceuticals Inc
S49 have decreased by 0%.
Payout Ratio
Supernus Pharmaceuticals Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for S49 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
S49 Price
Supernus Pharmaceuticals Inc
| Average Annual Return | 11.2% |
| Standard Deviation of Annual Returns | 26.5% |
| Max Drawdown | -26% |
| Market Capitalization | 2.8B EUR |
| Shares Outstanding | 54 965 316 |
| Percentage of Shares Shorted |
N/A
|
